Features | Partner Sites | Information | LinkXpress
Sign In
Demo Company

MRI T1 Mapping Technique Diagnoses Genetic Disorder That Attacks the Heart, Brain, and Nerves

By Medimaging International staff writers
Posted on 16 Oct 2013
A genetic disorder that attacks multiple organs and typically causes fatal heart complications can be detected using a new magnetic resonance imaging (MRI) technique. This new diagnostic application has resulted in updated clinical guidelines for the diagnosis and treatment of Fabry disease in Canada.

The University of Alberta’s (Edmonton, AB, Canada) Faculty of Medicine & Dentistry researchers Drs. Gavin Oudit and Richard Thompson worked with Faculty colleagues Drs. Kelvin Chow and Alicia Chan on the discovery, as well as Dr. Aneal Khan from the University of Calgary (Alberta, Canada). The findings were published online before August 6, 2013, in the journal, Circulation-Cardiovascular Imaging, and involved 31 Alberta patients who have the disease.

Dr. Thompson and trainee Dr. Chow developed the MRI technique known as T1 mapping, which can identify heart damage and changes at early stages, earlier than regular MRI scans or ultrasound. When this type of MRI technology is used on patients with Fabry disease, the scans can detect both the disease and the degree of damage to the heart. The T1 mapping technology developed by the group can be easily programmed onto MRI scans worldwide.

“This test can uniquely identify Fabry disease by detecting microscopic changes in the heart muscle structure that are not visible on regular images,” said Dr. Thompson, who works in the department of biomedical engineering. “Fabry disease can look like other diseases if you only look at the whole heart structure or function, but this T1 mapping test, that can detect the tiniest changes in the heart, could identify all the patients with Fabry disease. It is very likely that this technique will become a key part in clinical examination of patients with Fabry disease. This finding will advance the clinical care of these patients around the world. The implications will be widespread. Heart disease is the number one cause of death for patients with Fabry disease. The earlier the disease can be pinpointed, the sooner treatment can start. The treatment for the disease halts the condition and prevents serious damage to the heart.”

Fabry disease is a genetic metabolic disorder that destroys the enzyme involved in fat metabolism. This enzyme dissolves fat so without it, those with the disease accumulate lethal fat deposits in their heart, kidneys, and brain. The condition affects 1 in 1,500 to 3,000 people, but was first believed to be a rare disease. Various countries now screen newborns for the condition that costs USD 200,000 yearly to treat through monthly infusions called enzyme replacement therapy. Symptoms of the disease include heart failure, blackouts, thickened walls of the heart, exercise intolerance, fluid accumulation in the legs, inability to lie down, strokes, tingling in the hands and feet, and changes in skin pigmentation.

The T1 mapping test can both detect the disease and evaluate damage to the heart. Dr. Oudit reported that this new MRI technique “is a wonderful story of collaboration--of patients, clinicians, scientists, and industry working together to find a new diagnostic tool.”

“As an organization, we are excited to be part of these developments through the research from the University of Alberta,” said Mauro Chies, acting vice-president of clinical supports for Alberta Health Services. “This is a significant advancement in the detection of disease in a noninvasive environment for our patients. We hope to be able to advance these sequences on our MRIs in the near future, and look for ways to use it to evaluate and detect other disease conditions.”

The project was done in collaboration with Siemens Canada, Ltd. and Siemens Healthcare USA, Inc. (Malvern, PA, USA).

Related Links:

University of Alberta
University of Calgary
Siemens Healthcare



view channel
Image: Multimodal CT images obtained 2 hours 18 minutes after symptom onset in an 87-year-old woman with an NIH Stroke Scale of 15 and left hemisphere symptoms (Photo courtesy of Radiology 2015:257;2;510-520, and RSNA 2015).

Faster and Simpler Treatment for Stroke Patients Using Multiphase CT

The results of a new study show that multiphase Computed Tomography (CT) angiography brain-imaging could enable clinicians to treat Acute Ischemic Stroke (AIS) patients faster, and better, potentially saving lives.... Read more

Nuclear medicine

view channel
Image: The whole body of a rat can be imaged for blood clots with one PET scan, overlaid here on an MRI image, using the FBP8 probe. The arrow points to a blood clot (Photo courtesy of the American Chemical Society).

Single PET Scan Could Replace Multiple Modalities in Detecting Blood Clots

Researchers have presented an experimental technique that could be used to discover blood clots using a single, fast, whole-body scan, at the 250th National Meeting and Exposition of the American Chemical... Read more

General/Advanced Imaging

view channel

Leading Vendor to Implement and Install Enterprise Imaging Platform for UK NHS

An agreement has been announced by a leading imaging platform provider for the implementation of the first Enterprise Imaging platform, part of a long-term agreement for the management of imaging data, for the UK City Hospitals Sunderland NHS Foundation Trust. The agreement covers the capture, storage, and exchange of... Read more

Imaging IT

view channel

Carestream Updates Healthcare IT Platform

Carestream has released updates for an advanced Internet Technology (IT) healthcare platform at the Röntgenveckan Radiology congress in Malmo (Sweden). The IT platform facilitates collaboration by enabling sharing of critical patient information such as Radiology images, videos, reports, and services with groups outside... Read more

Industry News

view channel

Viztek Acquired by Konica Minolta to Complement End-to-End Healthcare IT Solutions

Konica Minolta Medical Imaging (Wayne, NJ, USA), a leading medical diagnostic primary imaging provider, has announced the completed acquisition of Viztek (Garner, NC, USA), a company providing Healthcare Internet Technology solutions. The acquisition enhances Konica Minolta’s end-to-end healthcare IT capabilities, including... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.